Protega Drug Patent Portfolio
Protega owns 1 orange book drug protected by 2 US patents Given below is the list of Protega's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10314788 | Pharmaceutical compositions configured to deter dosage form splitting | 12 Aug, 2028 | Active |
| US7955619 | Abuse resistant drugs, method of use and method of making | 12 Aug, 2028 | Active |
Latest Legal Activities on Protega's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Protega.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Correspondence Address Change | 18 Aug, 2024 | US7955619 |
| Correspondence Address Change | 21 Dec, 2023 | US7955619 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Jun, 2022 | US10314788 |
| Payment of Maintenance Fee, 12th Yr, Small Entity | 08 Jun, 2022 | US7955619 |
| Change in Power of Attorney (May Include Associate POA) | 20 Oct, 2020 | US7955619 |
| Email Notification | 20 Oct, 2020 | US7955619 |
| Correspondence Address Change | 15 Oct, 2020 | US7955619 |
| Email Notification | 08 Sep, 2020 | US10314788 |
| Change in Power of Attorney (May Include Associate POA) | 08 Sep, 2020 | US10314788 |
| Correspondence Address Change | 03 Sep, 2020 | US10314788 |
| Change in Power of Attorney (May Include Associate POA) | 27 Aug, 2020 | US7955619 |
| Email Notification | 27 Aug, 2020 | US7955619 |
| Change in Power of Attorney (May Include Associate POA) | 26 Aug, 2020 | US10314788 |
| Email Notification | 26 Aug, 2020 | US10314788 |
| Mail O.P. Petition Decision | 28 Apr, 2020 | US10314788 |
Protega's Family Patents
Protega Drug List
Given below is the complete list of Protega's drugs and the patents protecting them.
1. Roxybond
Roxybond is protected by 2 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10314788 | Pharmaceutical compositions configured to deter dosage form splitting |
12 Aug, 2028
(2 years from now)
| Active |
| US7955619 | Abuse resistant drugs, method of use and method of making |
12 Aug, 2028
(2 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Roxybond's drug page